4.4 Article

Imaging Single Endocytic Events Reveals Diversity in Clathrin, Dynamin and Vesicle Dynamics

期刊

TRAFFIC
卷 12, 期 10, 页码 1394-1406

出版社

WILEY-BLACKWELL
DOI: 10.1111/j.1600-0854.2011.01235.x

关键词

clathrin; dynamin; endocytosis; Epi-TIR; TIRF; total internal reflection microscopy

资金

  1. NSF [BES-0620813]
  2. NIH [GM87977]
  3. Rockefeller University

向作者/读者索取更多资源

The dynamics of clathrin-mediated endocytosis can be assayed using fluorescently tagged proteins and total internal reflection fluorescence microscopy. Many of these proteins, including clathrin and dynamin, are soluble and changes in fluorescence intensity can be attributed either to membrane/vesicle movement or to changes in the numbers of individual molecules. It is important for assays to discriminate between physical membrane events and the dynamics of molecules. Two physical events in endocytosis were investigated: vesicle scission from the plasma membrane and vesicle internalization. Single vesicle analysis allowed the characterization of dynamin and clathrin dynamics relative to scission and internalization. We show that vesicles remain proximal to the plasma membrane for variable amounts of time following scission, and that uncoating of clathrin can occur before or after vesicle internalization. The dynamics of dynamin also vary with respect to scission. Results from assays based on physical events suggest that disappearance of fluorescence from the evanescent field should be re-evaluated as an assay for endocytosis. These results illustrate the heterogeneity of behaviors of endocytic vesicles and the importance of establishing suitable evaluation criteria for biophysical processes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biology

Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A

Cristina Olivieri, Caitlin Walker, Adak Karamafrooz, Yingjie Wang, V. S. Manu, Fernando Porcelli, Donald K. Blumenthal, David D. Thomas, David A. Bernlohr, Simon M. Sandford, Susan S. Taylor, Gianluigi Veglia

Summary: The fusion of the dynamic J-domain to PKA-C disrupts the internal allosteric network, causing attenuation of nucleotide/PKI binding cooperativity. This reduced allosteric cooperativity alters specific recognitions and interactions between substrates and regulatory partners, contributing to dysregulation exhibited by PKA-C-DNAJB1.

COMMUNICATIONS BIOLOGY (2021)

Article Pathology

Morphologic and Molecular Findings in Myxoid Hepatic Adenomas

Daniel J. Rowan, Saba Yasir, Zongming E. Chen, Taofic Mounajjed, Sibel Erdogan Damgard, Lisa Cummins, Lizhi Zhang, Emma Whitcomb, Vince Falck, Sanford M. Simon, Aatur D. Singhi, Michael S. Torbenson

Summary: Myxoid hepatic adenomas are a rare subtype of hepatic adenomas that predominantly occur in older individuals and have an elevated risk of malignant transformation. They are characterized by the combined inactivation of HNF1A and additional mutations that cluster in the PKA pathway.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Article Oncology

Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening

Gadi Lalazar, David Requena, Lavoisier Ramos-Espiritu, Denise Ng, Patrick D. Bhola, Ype P. de Jong, Ruisi Wang, Nicole J. C. Narayan, Bassem Shebl, Solomon Levin, Eleftherios Michailidis, Mohammad Kabbani, Koen O. A. Vercauteren, Arlene M. Hurley, Benjamin A. Farber, William J. Hammond, James A. Saltsman, Ethan M. Weinberg, J. Fraser Glickman, Barbara A. Lyons, Jessica Ellison, Erik Schadde, Martin Hertl, Jennifer L. Leiting, Mark J. Truty, Rory L. Smoot, Faith Tierney, Tomoaki Kato, Hans-Guido Wendel, Michael P. LaQuaglia, Charles M. Rice, Anthony Letai, Philip Coffino, Michael S. Torbenson, Michael Ortiz, Sanford M. Simon

Summary: Therapeutics informed by genomics have not been effective for fibrolamellar carcinoma (FLC). A functional drug screen identified that inhibitors of TOPO1 and HDAC, along with napabucasin, showed efficacy on patient-derived xenografts (PDX) of FLC. Inhibiting Bcl-xL in combination with these drugs also showed synergy in treating FLC.

CANCER DISCOVERY (2021)

Article Biochemistry & Molecular Biology

ST6Gal-I-mediated sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion

Tejeshwar C. Rao, Reena R. Beggs, Katherine E. Ankenbauer, Jihye Hwang, Victor Pui-Yan Ma, Khalid Salaita, Susan L. Bellis, Alexa L. Mattheyses

Summary: This study explores the influence of heterogeneity within the glycocalyx on cell adhesion mechanics and signaling. Specifically, it investigates the role of specific glycosylation subtypes, such as the addition of sialic acid to terminal glycans, in altering receptor function and regulating cell mechanics. The researchers found that high activity of the sialyltransferase ST6Gal-I promotes increased integrin forces and spreading in cancer cells, and these phenotypes are EGFR-specific. They also discovered that different aspects of cell mechanics, such as tension, contractility, adhesion, spreading, proliferation, and invasion, are regulated by different signaling pathways. Additionally, the study demonstrates that high ST6Gal-I activity leads to sustained EGFR membrane retention, highlighting its importance as a key regulator of cell mechanics and motility.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Medicine, Research & Experimental

Desmosomes undergo dynamic architectural changes during assembly and maturation

Reena R. Beggs, Tejeshwar C. Rao, William F. Dean, Andrew P. Kowalczyk, Alexa L. Mattheyses

Summary: The study revealed structural rearrangements in desmosomes during maturation, with some parts of desmoplakin showing decreased plaque-to-plaque distance and increased plaque length, while other parts remained constant. This structural reorganization was correlated with desmosome maturation and adhesive strength, suggesting that the architectural organization of desmosomes can indicate their maturation state. Additionally, migrating cells showed differences in desmosome structure compared to those forming at the wound edge, highlighting the impact of cell migration on desmosome assembly and architecture.

TISSUE BARRIERS (2022)

Article Multidisciplinary Sciences

Imaging vesicle formation dynamics supports the flexible model of clathrin-mediated endocytosis

Tomasz J. Nawara, Yancey D. Williams, Tejeshwar C. Rao, Yuesong Hu, Elizabeth Sztul, Khalid Salaita, Alexa L. Mattheyses

Summary: By utilizing STAR microscopy, researchers quantified the nanoscale dynamics of clathrin-coat shape change during vesicle assembly, revealing multiple productive mechanisms of vesicle formation and advocating for the flexible model of CME.

NATURE COMMUNICATIONS (2022)

Article Cell & Tissue Engineering

Human liver organoids for disease modeling of fibrolamellar carcinoma

Nicole J. C. Narayan, David Requena, Gadi Lalazar, Lavoisier Ramos-Espiritu, Denise Ng, Solomon Levin, Bassem Shebl, Ruisi Wang, William J. Hammond, James A. Saltsman III, Helmuth Gehart, Michael S. Torbenson, Hans Clevers, Michael P. LaQuaglia, Sanford M. Simon

Summary: In this study, patient-derived organoids were successfully developed and used as a model system to recapitulate the histologic morphology, immunohistochemistry, and transcriptome of fibrolamellar carcinoma (FLC). This model system shows promise for improving our understanding of this rare cancer and for drug testing and development.

STEM CELL REPORTS (2022)

Article Biophysics

Defining domain-specific orientational order in the desmosomal cadherins

William F. Dean, Alexa L. Mattheyses

Summary: This study investigates the architecture of desmosomal cadherins (DCs) and their role in cell adhesion through fluorescence microscopy. The results show significant structural differences between the extracellular and intracellular domains of DCs, with extracellular adhesive interactions playing a predominant role in their organization.

BIOPHYSICAL JOURNAL (2022)

Article Oncology

Oncogenic Addiction of Fibrolamellar Hepatocellular Carcinoma to the Fusion Kinase DNAJB1-PRKACA

Christoph Neumayer, Denise Ng, Caroline S. Jiang, Adam Qureshi, Gadi Lalazar, Roger Vaughan, Sanford M. Simon

Summary: The fusion gene DNAJB1-PRKACA is found to be a recurrent mutation in fibrolamellar hepatocellular carcinoma (FLC). Continued expression of DNAJB1-PRKACA is essential for tumor growth and its inhibition can lead to cell death. This discovery has implications for investigating other fusion genes in pediatric cancers and advancing precision therapies.

CLINICAL CANCER RESEARCH (2023)

Article Biochemistry & Molecular Biology

Single molecule microscopy reveals diverse actions of substrate sequences that impair ClpX AAA plus ATPase function

Xiao Wang, Sanford M. Simon, Philip Coffino

Summary: This study used single molecule experiments to measure the dwell time of substrates interacting with the AAA+ ATPase unfoldase/translocase ClpX, finding that tail length and composition of the substrates affect substrate retention during futile unfolding. Both polyG and GAr have inhibitory effects on unfolding, but act differently.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Medicine, Research & Experimental

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma

Bassem Shebl, Denise Ng, Gadi Lalazar, Carly Rosemore, Tova M. Finkelstein, Rachael D. Migler, Guangrong Zheng, Peiyi Zhang, Caroline S. Jiang, Adam Qureshi, Roger Vaughan, Mark Yarchoan, Ype P. de Jong, Charles M. Rice, Philip Coffino, Michael V. Ortiz, Daohong Zhou, Sanford M. Simon

Summary: Fibrolamellar hepatocellular carcinoma (FLC) is a rare and lethal liver cancer with no effective systemic therapy. Inhibiting the antiapoptotic protein BCL-XL has shown synergy with various systemic therapies for FLC cells in vitro. However, the physiological expression of BCL-XL in platelets has hindered previous attempts to target this vulnerability in other cancers.

JCI INSIGHT (2022)

Article Biophysics

DrSTAR: Tracking real-time nanometer axial changes

Tomasz J. Nawara, William F. Dean, Alexa L. Mattheyses

Summary: Protein interactions with the plasma membrane play a crucial role in cell viability, but our understanding of how key proteins sense or induce unfavorable membrane shapes is limited. STAR microscopy provides high-resolution imaging of protein dynamics at the plasma membrane, but data processing is time-consuming. To address this, we present DrSTAR, a user-friendly MATLAB-based package that improves data processing efficiency, allowing for the study of nanometer-scale changes in protein distribution.

BIOPHYSICAL JOURNAL (2023)

Review Oncology

Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma

Sanford M. Simon

Summary: The fight against rare cancers is challenged by issues such as misdiagnosis, lack of information and tools, limited samples, and inadequate funding. However, studying rare cancers has led to important discoveries in cancer biology, such as the identification of tumor suppressor genes. Fibrolamellar hepatocellular carcinoma (FLC) is a rare and difficult-to-diagnose liver cancer that primarily affects young individuals. Through a personal journey, Sanford Simon shares insights into whether FLC is a single cancer type or a collection of similar phenotypes, and its genetic inheritance or somatic mutation origins.

NATURE REVIEWS CANCER (2023)

Article Gastroenterology & Hepatology

Clinical and demographic predictors of survival for fibrolamellar carcinoma patients-A patient community, registry-based study

Amichai Berkovitz, Rachael D. Migler, Adam Qureshi, Carly Rosemore, Michael S. Torbenson, Roger Vaughan, Erin Marcotte, Sanford M. Simon

Summary: Fibrolamellar hepatocellular carcinoma (FLC) is a rare primary liver cancer primarily affecting adolescents and young adults. Female gender is associated with improved survival, while the presence of 10 or more tumors within the liver and metastases at diagnosis are associated with worse survival. This study utilized a patient community-based FLC registry to highlight the importance of rare tumor registries in advancing clinical and scientific discoveries.

HEPATOLOGY COMMUNICATIONS (2022)

暂无数据